A new paper in Biology Methods & Protocols, published by Oxford University Press, shows it may be possible to design vaccines that will induce a stronger immune response to infecting pathogens, such as the virus causing COVID-19.
Ispire Technology Sells 2.05 Million Shares at $6.00
Ispire Technology Announces Pricing of $12.3 Million Public Offering LOS ANGELES, March 22, 2024 /PRNewswire/ — Ispire Technology Inc. (“Ispire” or the “Company”) (NASDAQ: ISPR),